Healthcare sector | Medical Devices industry
| Price | $6.1 |
|---|---|
| Shares Outstanding | 27.23M |
| All-Time Low | $4.13 |
| 52-Week Low | $5.48 |
| Net Cash / Share | $0.48 |
|---|---|
| Net Current Assets / Share | $3.37 |
| Net Tangible Assets / Share | $5.54 |
| Shares Outstanding Ave Change (Annual) | 1.69% |
| Shares Δ YoY | 4.19% |
| Avg CA Burn (Annual %) | -16.64% (as of 3-8-2026) |
| Avg CA Burn (Quarterly %) | 1.77% (as of 3-8-2026) |
| Max Earning Power / Share | $-1.49 |
|---|---|
| Adjusted Earning Power |
$-2.49
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
|
| Non-Cash Charges to Market Cap |
3.05%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
|
| Avg EBITDA (5Y) | 7.7M (as of 3-8-2026) |
| Avg EBITDA (5Q) | 0 (as of 3-8-2026) |
| Avg Net Income (5Y) | -57.1M (as of 3-8-2026) |
| Avg Net Income (5Q) | -6.5M (as of 3-8-2026) |
| Dividend indicators | Value | Date |
|---|---|---|
| Current Dividend Streak | No | 3-8-2026 |
| Consecutive Years Paid | No | 3-8-2026 |
| Pays Dividend | No | 3-8-2026 |
| Income indicators | Value | Date |
|---|---|---|
| EBITDA Positive | No | 3-8-2026 |
| Net Income Positive | No | 3-8-2026 |
| Current Dividend Streak | No | 3-8-2026 |
Pick a metric to view its history table and chart.
Formula: Tangible Book Value / shares from balance statements. Includes 6 quarterly + 4 annual.
Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).
| Report Date | Period | TBV / Share | Tangible Book Value | Shares Used |
|---|---|---|---|---|
| 2025-12-31 | Quarterly | $5.54 | 150.8M ($150,770,000) | 27.2M (27,232,350) |
| 2025-09-30 | Quarterly | $5.69 | 154.4M ($154,431,000) | 27.1M (27,148,482) |
| 2025-06-30 | Quarterly | $5.75 | 155.4M ($155,432,000) | 27M (27,040,390) |
| 2025-03-31 | Quarterly | $5.82 | 156.5M ($156,485,000) | 26.9M (26,887,242) |
| 2024-12-31 | Quarterly | $5.60 | 133.9M ($133,902,000) | 23.9M (23,902,338) |
| 2024-12-31 | Annual | $5.60 | 133.9M ($133,902,000) | 23.9M (23,902,338) |
| 2024-09-30 | Quarterly | $5.94 | 141.5M ($141,472,000) | 23.8M (23,817,704) |
| 2023-12-31 | Annual | $6.98 | 160.2M ($160,164,000) | 22.9M (22,941,643) |
| 2022-12-31 | Annual | $11.52 | 264.4M ($264,377,000) | 22.9M (22,941,643) |
| 2021-12-31 | Annual | $12.19 | 277.1M ($277,101,000) | 22.7M (22,731,586) |
Revenue from income statements. Includes 4 annual.
Chart plots one annual Revenue point per report date.
| Report Date | Revenue |
|---|---|
| 2024-12-31 | 335.7M ($335,705,000) |
| 2023-12-31 | 315.7M ($315,660,000) |
| 2022-12-31 | 377.2M ($377,241,000) |
| 2021-12-31 | 358M ($358,003,000) |
Historical cash dividends per share from Yahoo ex-dividend dates.
| Date | Dividend / Share |
|---|---|
| No dividend payment history available yet | |
| Date | Shares Outstanding | Delta |
|---|---|---|
| 2026-03-05 | 27,232,350 | +83,868 |
| 2025-11-10 | 27,148,482 | +108,092 |
| 2025-09-18 | 27,040,390 | -10 |
| 2025-08-12 | 27,040,400 | +153,200 |
Latest short-interest change: 1,208,558 shares (4.48% of float) | Days to cover: 3.81
| Date | Short Interest | Delta | Δ % |
|---|---|---|---|
| 2026-03-12 | 1,208,558 shares | +235,428 | +24.19% |
| 2026-02-27 | 973,130 shares | +154,681 | +18.90% |
| 2026-02-11 | 818,449 shares | +46,881 | +6.08% |
Volume/ratio use shares outstanding as of the event date (frozen).
| Date | Volume | Shares Outstanding | Volume / Shares | Price |
|---|---|---|---|---|
| No interesting volume events | ||||
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One and Inogen Rove, an ambulatory solutions for long-term oxygen therapy; Rove 4, a portable oxygen concentrator; Inogen At Home stationary oxygen concentrators; Simeox airway clearance; batteries; and related accessories. It also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.